Anti-biofilm dressing products help manage large wounds, thereby, reducing the risk of infection. Treating wounds with an antimicrobial or bacteriostatic dressing in an alginate or polymeric foam form will help prevent reformation of biofilms. Anti-biofilm agents can be used to prevent biofilm formation or to prevent reformation after debridement, thereby improving the wound healing.

Market Dynamics:

Increasing incidence of chronic diseases, increasing burden of chronic wounds, growing geriatric population, increasing number of surgical procedures, and high demand for advanced wound care products are major factors expected to propel the growth of the global anti-biofilm wound dressing market during the forecast period.

For instance, in October 2021, Imbed Biosciences received US$ 800,000 in a Commercialization Readiness Pilot (CRP) grant from the National Institute for Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to support late-stage development of a next-generation wound dressing that can kill bacteria hidden inside the biofilms in wounds and accelerate wound healing.

Key features of the study:

• This report provides in-depth analysis of the global anti-biofilm wound dressing market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global anti-biofilm wound dressing market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include 3M, Convatec Group PLC, Smith & Nephew PLC, Urgo Medical, and Coloplast Corporation, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global anti-biofilm wound dressing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti-biofilm wound dressing market.

Detailed Segmentation:

• Global Anti-Biofilm Wound Dressing Market, By Mode of Mechanism:
  • Physical
  • Chemical
  • Biological
• Global Anti-Biofilm Wound Dressing Market, By Application:
  • Acute Wounds
  • Chronic Wounds
• Global Anti-Biofilm Wound Dressing Market, By Geography:
  • North America
  • Latin America Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles:
  • 3M
  • Convatec Group PLC
  • Smith & Nephew PLC
  • Urgo Medical,
  • Coloplast Corporation